Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Safari, Z; Gérard, P.
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).
Cell Mol Life Sci. 2019; 76(8):1541-1558 Doi: 10.1007/s00018-019-03011-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Safari Zahra
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
NAFLD is currently the main cause of chronic liver disease in developed countries, and the number of NAFLD patients is growing worldwide. NAFLD often has similar symptoms to other metabolic disorders, including type 2 diabetes and obesity. Recently, the role of the gut microbiota in the pathophysiology of many diseases has been revealed. Regarding NAFLD, experiments using gut microbiota transplants to germ-free animal models showed that fatty liver disease development is determined by gut bacteria. Moreover, the perturbation of the composition of the gut microbiota has been observed in patients suffering from NAFLD. Numerous mechanisms relating the gut microbiome to NAFLD have been proposed, including the dysbiosis-induced dysregulation of gut endothelial barrier function that allows for the translocation of bacterial components and leads to hepatic inflammation. In addition, the various metabolites produced by the gut microbiota may impact the liver and thus modulate NAFLD susceptibility. Therefore, the manipulation of the gut microbiome by probiotics, prebiotics or synbiotics was shown to improve liver phenotype in NAFLD patients as well as in rodent models. Hence, further knowledge about the interactions among dysbiosis, environmental factors, and diet and their impacts on the gut-liver axis can improve the treatment of this life-threatening liver disease and its related disorders.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Animals, Inbred Strains -
Dysbiosis - immunology
Dysbiosis - microbiology
Dysbiosis - pathology
Dysbiosis - therapy
Gastrointestinal Microbiome -
Humans -
Immune System - microbiology
Inflammasomes - immunology
Non-alcoholic Fatty Liver Disease - immunology
Non-alcoholic Fatty Liver Disease - microbiology
Non-alcoholic Fatty Liver Disease - pathology
Non-alcoholic Fatty Liver Disease - therapy
Prebiotics - administration & dosage
Probiotics - administration & dosage
Specific Pathogen-Free Organisms -

Find related publications in this database (Keywords)
Gut microbiota
Non-alcoholic fatty liver disease
Germ-free animals
Dysbiosis
Metabolic syndrome
Bile acids
Intestinal permeability
Antibiotics
Probiotics
Prebiotics
© Med Uni Graz Impressum